Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001085146-25-000947·Ascendis Pharma A/S
Schedule 13G ownership disclosure
ASCENDIS PHARMA A/S
Common Stock · CUSIP: 04351P101
Event date: 2024-12-31
- Filing-level shares
- 4,075,214.00
- Percent of class
- 9.18%
- Westfield Capital Management Company, L.P.
Shares: 4,075,214.00 · Class: 9.18%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-25-000947
- Form type
- SCHEDULE 13G/A
- Filer
- Ascendis Pharma A/S
- CIK
- CIK 1612042
- Filed
- Feb 10, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership